Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The body of scientific literature linking Wnts and Wnt-associated proteins to human disease processes continues to grow in parallel with new discoveries from basic science laboratories that further characterize the elaborate cellular events following the binding of Wnts to their receptors. While Wnt-mediated signaling has long been known to play a major role in human carcinogenesis, accumulating evidence indicates that Wnts are also important mediators of inflammation and recovery from injury. The binding of secreted Wnt ligands to their receptors offers an attractive and accessible target for therapeutic regulation of these signaling pathways. Several promising preliminary studies have already addressed potential avenues for the manipulation of Wnt signaling in disease processes. This review will focus on disease processes involving the regulation of Wnt signaling at the level of Wnt binding to its target receptors. Wnt proteins, Wnt receptors, and secreted Wnt inhibitors are attractive as potential therapeutic agents and targets due to their extracellular location. In addition, since Wnt signaling results in a diverse array of downstream intracellular events, many of which are not fully understood, the targeting of this pathway at the most upstream site of pathway activation also provides a strategic advantage for therapy. As the list of Wnt-related diseases continues to grow, advances in our understanding of the biochemical and molecular mechanisms underlying Wnt signaling may ultimately translate into innovative ways to treat Wnt-related disease processes in patients.
Alonso,
Stem cells in the skin: waste not, Wnt not.
2003, Pubmed
Alonso,
Stem cells in the skin: waste not, Wnt not.
2003,
Pubmed
Bennett,
Regulation of Wnt signaling during adipogenesis.
2002,
Pubmed
Bernier,
Pharmacological chaperones: potential treatment for conformational diseases.
2004,
Pubmed
Bhanot,
A new member of the frizzled family from Drosophila functions as a Wingless receptor.
1996,
Pubmed
Bouillet,
A new mouse member of the Wnt gene family, mWnt-8, is expressed during early embryogenesis and is ectopically induced by retinoic acid.
1996,
Pubmed
,
Xenbase
Cappuccio,
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death.
2005,
Pubmed
Caricasole,
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain.
2004,
Pubmed
Carr,
Gene-expression profiling in human cutaneous melanoma.
2003,
Pubmed
Chen,
SKI activates Wnt/beta-catenin signaling in human melanoma.
2003,
Pubmed
Cheyette,
Ryk: another heretical Wnt receptor defies the canon.
2004,
Pubmed
Cong,
Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
2004,
Pubmed
Finch,
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action.
1997,
Pubmed
,
Xenbase
Funayama,
Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling.
1995,
Pubmed
,
Xenbase
Gregory,
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow.
2003,
Pubmed
Gregory,
Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow.
2005,
Pubmed
Grotewold,
The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death.
2002,
Pubmed
He,
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
2005,
Pubmed
He,
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.
2004,
Pubmed
He,
A member of the Frizzled protein family mediating axis induction by Wnt-5A.
1997,
Pubmed
,
Xenbase
He,
Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
2005,
Pubmed
Hussain,
Wnt impacts growth and differentiation in ex vivo liver development.
2004,
Pubmed
Huusko,
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
2004,
Pubmed
Häusler,
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
2004,
Pubmed
Kanazawa,
Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes.
2004,
Pubmed
Kaykas,
Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization.
2004,
Pubmed
Kléber,
Wnt signaling and the regulation of stem cell function.
2004,
Pubmed
Kohn,
Wnt and calcium signaling: beta-catenin-independent pathways.
2005,
Pubmed
Kremenevskaja,
Wnt-5a has tumor suppressor activity in thyroid carcinoma.
2005,
Pubmed
Lee,
Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma.
2004,
Pubmed
Liang,
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.
2003,
Pubmed
Loughlin,
Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females.
2004,
Pubmed
Malbon,
Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance?
2001,
Pubmed
Mao,
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.
2001,
Pubmed
,
Xenbase
Maye,
Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway.
2004,
Pubmed
Mazieres,
Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis.
2005,
Pubmed
Mazieres,
Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
2005,
Pubmed
McCrea,
A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin.
1991,
Pubmed
,
Xenbase
McMahon,
Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis.
1989,
Pubmed
,
Xenbase
Merle,
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.
2004,
Pubmed
Mikami,
Efficacy of Wnt-1 monoclonal antibody in sarcoma cells.
2005,
Pubmed
Moon,
The promise and perils of Wnt signaling through beta-catenin.
2002,
Pubmed
,
Xenbase
Moon,
WNT and beta-catenin signalling: diseases and therapies.
2004,
Pubmed
Morin,
Wnt signaling in human cancer.
2003,
Pubmed
Morizono,
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection.
2005,
Pubmed
Nagayama,
Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas.
2005,
Pubmed
Pandur,
Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis.
2002,
Pubmed
,
Xenbase
Perantoni,
Renal development: perspectives on a Wnt-dependent process.
2003,
Pubmed
Rattner,
A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors.
1997,
Pubmed
Rhee,
Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas.
2002,
Pubmed
Riggleman,
Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless.
1990,
Pubmed
Rijsewijk,
The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless.
1987,
Pubmed
Roth,
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.
2000,
Pubmed
Rubinfeld,
Association of the APC gene product with beta-catenin.
1993,
Pubmed
Rubinfeld,
Stabilization of beta-catenin by genetic defects in melanoma cell lines.
1997,
Pubmed
Seale,
Adult stem cell specification by Wnt signaling in muscle regeneration.
2003,
Pubmed
Sen,
Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation.
2001,
Pubmed
Shum,
Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo.
1999,
Pubmed
Su,
Association of the APC tumor suppressor protein with catenins.
1993,
Pubmed
Surendran,
Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
2005,
Pubmed
Surendran,
CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury.
2003,
Pubmed
Suzuki,
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
2004,
Pubmed
Taketo,
Shutting down Wnt signal-activated cancer.
2004,
Pubmed
Tao,
Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos.
2005,
Pubmed
,
Xenbase
Terada,
Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats.
2003,
Pubmed
Terami,
Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes.
2004,
Pubmed
,
Xenbase
Veeman,
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
2003,
Pubmed
Vincan,
Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth.
2005,
Pubmed
Weeraratna,
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
2002,
Pubmed
Wehrli,
arrow encodes an LDL-receptor-related protein essential for Wingless signalling.
2000,
Pubmed
Weidinger,
When Wnts antagonize Wnts.
2003,
Pubmed
Willert,
Wnt proteins are lipid-modified and can act as stem cell growth factors.
2003,
Pubmed
,
Xenbase
Winn,
Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
2005,
Pubmed
Yamamoto,
Shisa promotes head formation through the inhibition of receptor protein maturation for the caudalizing factors, Wnt and FGF.
2005,
Pubmed
,
Xenbase
Yang-Snyder,
A frizzled homolog functions in a vertebrate Wnt signaling pathway.
1996,
Pubmed
,
Xenbase
You,
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.
2004,
Pubmed
You,
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.
2004,
Pubmed
van Gijn,
The wnt-frizzled cascade in cardiovascular disease.
2002,
Pubmed
